6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	GreenPower Unveils Innovative Heating Solution for Type A Nano BEAST All-Electric, Purpose-Built, Zero-Emission School Bus
8m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
13m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
18m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
18m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit

About

2.60USD+0.14 +5.69%

Closed • Updated at 13:34 GMT+00:00

Market Cap$254.56M

Volume1.37M

Beta2.35

RSI41.27

Gross Margin90.07%

Health TechnologyBiotechnology

Editas Medicine, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting

Editas Medicine Announces First Quarter 2026 Results and Business Updates

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates

Community Chat

Ask AI